Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified SettingJeffrey S. Morris, Dipen M. Maru, Mark J. Routbort et al.|Clinical Cancer Research|2020Cited by 35
Targeting cyclin-dependent kinase 9 by a novel inhibitor enhances radiosensitization and identifies Axl as a novel downstream target in esophageal adenocarcinomaOmkara Veeranki, Dipen M. Maru|Oncotarget|2019Cited by 13
Supplementary Table-12 from Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified SettingJeffrey S. Morris, Dipen M. Maru, Rajyalakshmi Luthra et al.|Unknown|2023Cited by 0
Supplementary Table-9 from Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified SettingJeffrey S. Morris, Dipen M. Maru, Michael J. Overman et al.|Unknown|2023Cited by 0
Supplementary Table-6 from Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified SettingJeffrey S. Morris, Dipen M. Maru, Rajyalakshmi Luthra et al.|Unknown|2023Cited by 0